急性冠脉综合征急性期他汀类药物治疗方案及剂量选择的临床研究

Clinical study on statin therapy and dose selection in treatment of patients with acute coronary syndrome in acute stage

  • 摘要: 目的 探讨急性冠脉综合征急性期他汀类药物治疗方案及剂量选择.方法 选择120例急性冠脉综合征急性期患者,通过随机数表法分为3组,即A组(阿托伐他汀20 rmg),B组(阿托伐他汀10 mg),C组(常规治疗).比较3组治疗效果.结果 治疗后,A组、B组总胆固醇(TC)、甘油三酯(TG)、低密度脂蛋白胆固醇(LDL-L)、超敏C反应蛋白(hs-CRP)水平均显著改善(P<0.05);在治疗后4周、8周时,A组TC、TG、LDL-C水平均比其他2组低(P<0.05),hs-CRP水平均低于其他2组(P<0.05),TC、LDL-C达标率均优于其他2组(P<0.05);A、B组阿托伐他汀治疗患者不良反应发生率无显著差异(P>0.05);通过对所有患者8个月的随访,A组患者心血管事件发生率显著低于其他2组(P<0.05).结论 在急性冠脉综合征急性期患者中,早期使用大剂量的阿托伐他汀效果显著,可达到有效的抗炎、降脂作用,降低心血管事件发生率.

     

    Abstract: Objective To explore the statin therapy and dose selection in treatment of patients with acute coronary syndrome in acute stage.Methods A total of 120 patients with acute coronary syndrome in acute stage were selected and randomly divided into the group A (atorvastatin 20 mg),group B (atorvastatin 10 mg) and group C (routine treatment).The effect was compared.Results After treatment,the levels of total cholesterol (TC),triglyceride (TG),low density lipoprotein cholesterol (LDL-L),and high sensitive C reactive protein (hs-CRP) significantly improved in the group A and group B (P < 0.05).After 4 weeks and 8 weeks of treatment,the levels of TC,TG,LDL-C in group A were significantly lower than the other two groups (P < 0.05),the hs-CRP was significantly lower than the other two groups (P < 0.05),and the TC,LDL-C standard rate were significantly better than the other two groups (P < 0.05).There was no significant difference in the incidence rate of adverse reactions between the group A and group B.After 8 months of follow up,the incidence rate of cardiovascular events in group A was significantly lower than the other two groups (P < 0.05).Conclusion Early use of large doses of atorvastatin is effective in treatment of patients with acute coronary syndrome in acute stage,and it can achieve the anti-inflammatory and lipid lowering effects,and reduce the incidence rate of cardiovascular events.

     

/

返回文章
返回